NCT07541014 TeleheartCR vs. Clinic-Based Cardiac Rehabilitation After Acute Coronary Syndrome
| NCT ID | NCT07541014 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Columbia University |
| Condition | Acute Coronary Syndrome (ACS) |
| Study Type | INTERVENTIONAL |
| Enrollment | 250 participants |
| Start Date | 2026-05-19 |
| Primary Completion | 2029-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 250 participants in total. It began in 2026-05-19 with a primary completion date of 2029-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cardiac rehabilitation (CR) is an effective evidence-based intervention that improves outcomes in patients with acute coronary syndrome (ACS), but many eligible patients do not complete the program. A hybrid CR intervention that combines telehealth, home-based, and clinic-based components (TeleheartCR) may increase participation by addressing barriers to access while maintaining the functional capacity benefits of traditional CR. The purpose of this study is to conduct a randomized controlled trial comparing TeleheartCR with traditional clinic-based CR in patients with ACS to evaluate differences in program adherence and pre-to-post program change in functional capacity.
Eligibility Criteria
Inclusion Criteria: * Age 18 years or older * Diagnosis of acute coronary syndrome within the past 12 months * Eligible for outpatient cardiac rehabilitation * Able to read and speak English or Spanish * Resides in New York State Exclusion Criteria: * Severe medical or psychiatric comorbidities that would prevent safe or adequate participation * High risk for adverse exercise-related cardiovascular events * Initiation of cardiac rehabilitation prior to enrollment (i.e., \>1 session completed) * Conditions that would interfere with safe or consistent participation in study procedures * Home environment or willingness not compatible with safe or adequate participation * Not expected to be available for follow-up during the study period * Current participation in another interventional clinical trial that may affect study outcomes
Contact & Investigator
Andrea T. Duran, PhD
PRINCIPAL INVESTIGATOR
Columbia University
Frequently Asked Questions
Who can join the NCT07541014 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Coronary Syndrome (ACS). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07541014 currently recruiting?
Yes, NCT07541014 is actively recruiting participants. Contact the research team at atd2127@cumc.columbia.edu for enrollment information.
Where is the NCT07541014 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT07541014 clinical trial?
NCT07541014 is sponsored by Columbia University. The principal investigator is Andrea T. Duran, PhD at Columbia University. The trial plans to enroll 250 participants.